E
Athira Pharma, Inc. ATHA
$0.36 $0.01885.51% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income 39.06% 47.80% -7.01% -1.98% 3.47%
Total Depreciation and Amortization 0.00% 0.00% 0.41% 0.00% -1.22%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -27.73% -22.99% -5.10% 25.11% 23.79%
Change in Net Operating Assets 45.24% -633.46% 113.30% 154.35% -74.32%
Cash from Operations 43.62% -12.99% -3.10% 13.46% 1.86%
Capital Expenditure -- -- 100.00% -460.00% --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -161.42% -115.59% -32.16% 103.82% 104.13%
Cash from Investing -161.42% -115.59% -32.09% 103.68% 104.05%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- 183.33% -91.89% -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -- 183.33% -91.89% -- --
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 23.53% -479.06% -213.52% 134.32% 35.38%